Manning & Napier Group’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$30.9M Sell
272,030
-26,935
-9% -$3.09M 0.35% 64
2023
Q4
$32.9M Sell
298,965
-47,951
-14% -$4.79M 0.39% 64
2023
Q3
$33.6M Sell
346,916
-2,647
-0.8% -$278K 0.42% 65
2023
Q2
$38.1M Buy
349,563
+72,070
+26% +$7.68M 0.44% 65
2023
Q1
$28.1M Sell
277,493
-1,258
-0.5% -$133K 0.33% 79
2022
Q4
$30.6M Buy
278,751
+5,212
+2% +$540K 0.38% 68
2022
Q3
$26.5M Sell
273,539
-3,571
-1% -$381K 0.35% 74
2022
Q2
$30.1M Buy
+277,110
New +$31.5M 0.35% 70

Other funds holding ABT

Manning & Napier Group's ABT Position: Q1 2024 in Review

Manning & Napier Group reduced its Abbott (ABT) stake by 9% in Q1 2024, selling an estimated $3.09M and leaving 272,030 shares worth $30.9M. The position accounts for 0.35% of the portfolio, ranked #64.

Manning & Napier Group first reported a position in ABT in Q2 2022 and has held it in 8 quarters since. The position peaked at $38.1M in Q2 2023. 2,912 funds tracked by Wall St. Rank hold ABT as of Q1 2024.

  • Manning & Napier Group held 272,030 shares of Abbott worth $30.9M as of Q1 2024.
  • Manning & Napier Group sold 26,935 Abbott shares in Q1 2024, an estimated $3.09M.
  • Abbott made up 0.35% of Manning & Napier Group's portfolio in Q1 2024, its #64 holding.
  • Manning & Napier Group first reported a position in Abbott in Q2 2022 and has held it in 8 quarters since.
  • Manning & Napier Group's Abbott position peaked at $38.1M in Q2 2023.
  • 2,912 funds tracked by Wall St. Rank held Abbott as of Q1 2024.

Based on Manning & Napier Group's 13F filing for Q1 2024, filed 15 Apr 2024.